Toggle navigation
Home
Search
Services
Blog
Contact
About
Mammalian Cells Expressing Fmo
Crespi, Charles L.
Gentest Corporation, Woburn, MA, United States
Search 27 grants from Charles Crespi
Search grants from Gentest Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Voltage-gated sodium channel regulation of neocortical development
Alcohol and Maternal Uterine Vascular Adaptations in Pregnancy
Animal Health & Sample Procurement Core
TGF-beta1 in Hematopoietic and Immune Cell Differentiati
Neurotrophic Factor-Like Effects of Non-Neurotrophic Cytokine Peptides
Recently added grants:
Examining the synergistic effects of cannabis and prescription opioid policies on chronic pain, opioid prescribing, and opioid overdose
Targeting UHRF1 in combinational immunotherapy
Precision Therapy for Neonatal Brain Injury
Targeting ATRX-Deficient Pediatric GBM
Enhanced cellular therapy for neonatal stroke
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
2R42ES006973-02
Application #
2018491
Study Section
Special Emphasis Panel (ZRG3-SSS-2 (01))
Project Start
1996-09-30
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Gentest Corporation
Department
Type
DUNS #
City
Woburn
State
MA
Country
United States
Zip Code
01801
Related projects
NIH 1997
R42 ES
Mammalian Cells Expressing Fmo
Crespi, Charles L. / Gentest Corporation
NIH 1996
R42 ES
Mammalian Cells Expressing Fmo
Crespi, Charles L. / Gentest Corporation
Comments
Be the first to comment on Charles Crespi's grant